As of 2024-12-12, the Intrinsic Value of Magenta Therapeutics Inc (MGTA) is
-6.33 USD. This MGTA valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.70 USD, the upside of Magenta Therapeutics Inc is
-1,004.42%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-6.33 USD
Intrinsic Value
MGTA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-6.33 - -6.33 |
-6.33 |
-1,004.42% |
P/E |
(6.45) - (23.16) |
(14.90) |
-2229.9% |
DDM - Stable |
(6.40) - (18.94) |
(12.67) |
-1911.6% |
DDM - Multi |
(4.92) - (12.32) |
(7.15) |
-1121.5% |
MGTA Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
42.44 |
Beta |
2.42 |
Outstanding shares (mil) |
60.66 |
Enterprise Value (mil) |
-20.19 |
Market risk premium |
5.00% |
Cost of Equity |
13.92% |
Cost of Debt |
5.00% |
WACC |
8.80% |